Theratechnologies Inc (NASDAQ:THTX)
| 1.59 Delayed Data As of 3:33pm ET |  -0.04 / -2.45%Today’s Change | 0.88 Today|||52-Week Range 4.96 | -54.97% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $77.3M |
Company Description
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
Contact Information
Theratechnologies, Inc. 2015 Peel Street Montréal Quã©bec H3A 1T8 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Paul Lévesque | President, Chief Executive Officer & Director |
| Philippe Dubuc | Chief Financial Officer & Senior Vice President |
| Christian Marsolais | Chief Medical Officer & Senior Vice President |
| Marie-Noël Colussi | Vice President-Finance |
| John Leasure | Global Commercial Officer |
